Get started
Author

Samuel R. Briggs

Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
2019 · Alexandra M. Miller, Ronak H. Shah, et al. · Nature · 630
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
2015 · Eli L. Diamond, Benjamin H. Durham, et al. · Cancer Discovery · 534
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
2016 · Elena I. Pentsova, Ronak H. Shah, et al. · Journal of Clinical Oncology · 418
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
2015 · Macarena I. de la Fuente, Robert J. Young, et al. · Neuro-Oncology · 193
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
2017 · Xuling Lin, Martin Fleisher, et al. · Neuro-Oncology · 114
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
2017 · Alissa A Thomas, Lauren E Abrey, et al. · Neuro-Oncology · 30
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Cerebrospinal fluid circulating tumor cells (CSF CTC) for real-time patient monitoring and response to treatment.
2017 · Rachna Malani, Martin Fleisher, et al. · Journal of Clinical Oncology · 4
Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade.
2018 · Bianca Santomasso, Aya Haggiagi, et al. · Journal of Clinical Oncology · 2
Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis (N6.001)
2018 · Rachna Malani, Aya Haggiagi, et al. · Neurology · 1
NTOX-14. THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
2017 · Rachna Malani, Aya Haggiagi, et al. · Neuro-Oncology · 1
Abstract 1498: Feasibility of 2-hydroxyglutarate 1H-MR spectroscopy for routine clinical glioma imaging
2015 · Macarena I. de la Fuente, Robert Young, et al. · Cancer Research · 1
AT-35INTERMITTENT HIGH DOSE (PULSATILE) ERLOTINIB FOR EGFRvIII MUTANT RECURRENT MALIGNANT GLIOMAS: A PILOT CLINICAL TRIAL
2014 · Andrew Lassman, Christian Grommes, et al. · Neuro-Oncology · 1
PDF
Mixed-Pattern Autoimmune Hemolytic Anemia with Multi-Organ Failure Temporally Associated with Semaglutide Initiation: A Case Report
2026 · Samuel R. Briggs, David Rabinovich, et al. · Journal of Maine Medical Center
From Covert Use to Structured Oversight: A Framework for Institutional Governance of Artificial Intelligence in Graduate Medical Education
2026 · Samuel R. Briggs, Bita Behrouzi, et al. · Journal of Maine Medical Center
PDF
Is Cannabis the New Tobacco? Small-cell Lung Cancer in a 34-year-old Male With Significant Cannabis Exposure
2023 · ARNAVI VARSHNEY, INNA PAVLYUK, et al. · CHEST Journal
PDF
Supplementary Methods, Figures 1 - 5, Tables 1 - 5 from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
2023 · Eli L. Diamond, Benjamin H. Durham, et al.
PDF
Supplementary Methods, Figures 1 - 5, Tables 1 - 5 from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
2023 · Eli L. Diamond, Benjamin H. Durham, et al.
Data from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
2023 · Eli L. Diamond, Benjamin H. Durham, et al.
Data from Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
2023 · Eli L. Diamond, Benjamin H. Durham, et al.
Cmet-04. Cerebrospinal Fluid Circulating Tumor Cells (csf Ctc) for Patient Monitoring and Response to Treatment
2017 · Rachna Malani, Martin Fleisher, et al. · Neuro-Oncology
PDF
Cerebrospinal Fluid Circulating Tumor Cells: A Novel Tool to Diagnose Leptomeningeal Metastases from Epithelial Tumors (P5.170)
2017 · Xuling Lin, Martin Fleisher, et al. · Neurology
The Likelihood of Developing Leptomeningeal Metastasis (LM) in Cancer Patients with Neurological Symptoms but Negative Neuroimaging and CSF Cytology (P4.237)
2016 · Aya Haggiagi, Xuling Lin, et al. · Neurology
Is Next Generation Sequencing (NGS) Ready for Routine Clinical Practice in Gliomas? Results of a Prospective Study Utilizing the MSK-IMPACT Assay
2015 · Antonio Marcilio Padula Omuro, Ahmet Zehir, et al. · Journal of Clinical Oncology
Works count: 24
Citation count: 1,934
H-index: 6
I10-index: 6
Year
Topic
Type